Mar 26, 2019 / 01:00PM GMT
Operator
Good morning and welcome to the Onconova Therapeutics Corporate Update and Year-end 2018 Financial Results Conference Call. (Operator Instructions)
At this time, I'd like to turn the call over to Avi Oler, Vice President of Corporate Development and General Counsel at Onconova.
Abraham Oler - Onconova Therapeutics, Inc. - VP of Corporate Development & General Counsel
Thank you, operator. Good morning and welcome to Onconova's Corporate Update and Year-end 2018 Financial and Operating Results Conference Call. This morning, we issued a press release with full year 2018 financial results, along with business updates. The release is available on our website.
On today's call, Dr. Steve Fruchtman, our President and Chief Executive Officer, will review the company's progress and recent business and clinical highlights and milestones. Then Dr. Rick Woodman, our Chief Medical Officer, will review our clinical development programs in greater detail. After that, Mark Guerin, our Chief Financial Officer, will review the financial results. Steve will
Full Year 2018 Onconova Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot